eMed : Blog

352 results found

Filter Options
eMeds 6 to follow in entrepreneurship
Ryan Amin
12/27/2013
Blog Resource
Summary:

See who made this week's list

Read More
Funding future for biotech is bright if you are prepared
Ryan Amin
12/24/2013
Blog Resource
Summary:

Ronald Lindsay, CEO of Zebra Biologics Inc., thinks changes in the biotech industry will lead to a trend of success for biotech companies. His company’s technology can be used as a platform to discover and develop bio-superior antibody therapeutics and complex drug targets. Zebra has just pulled in $9 million in its first investing round, and Lindsay thinks one of the biggest changes for the future of biotech is the availability of venture funding.

Read More
Let consumers be the innovators
Ryan Amin
1/7/2014
Blog Resource
Summary:

Advance directives are commonly used for end-of-life medical decisions, but through consumer research, MyDirectives' co-founder Jeff Zucker has learned they can be used to instantly make life better for all users, and not just those near death.

Read More
Does your medical invention consulting contract comply with U.S. laws?
Auvil Steven
8/10/2011
Blog Resource
Summary:

Physician-consultants and medical device startups often don’t realize that failure to draft a tight physician-consultant contract could result in violations of federal laws and criminal and civil penalties. Read more about the guidelines for these contracts.

Read More
Updated patent laws will change how device makers innovate
Auvil Steven
11/15/2011
Blog Resource
Summary:

How will medtech and biotech companies be affected by the recently approved Leahy-Smith America Invents Act? Read more for five things these companies need to know about the modernized patent laws.

Read More
Finding better ways to negotiate biotech intellectual property
Rita BaronFaust
11/6/2013
Blog Resource
Summary:

Healthcare entrepreneurs who have hit the intellectual property speed bump can relate to the appropriately named session, "Reducing Drag: New Approaches to IP Negotiation and Technology Licensing," at the Partnering for Cures conference earlier this week in New York City.

Read More
Biotech companies need to diversify, use new approaches to survive today
Baum Stephanie
10/26/2011
Blog Resource
Summary:

At this week's Biotech 2011 conference, speakers from Teva Pharmaceutical Industries and Merck spoke about how biotech companies can survive in this tough regulatory and economic environment.

Read More
An Investment Trend Could Hurt Startup IT Firms
Baum Stephanie
11/10/2011
Blog Resource
Summary:

Venture firms are approaching angel investor groups to co-invest at the growth stage of startups. Read more about the impact this could have on startup IT companies.

Read More
Are Synthes' corporate officers first of many to be punished by FDA?
Baum Stephanie
11/25/2011
Blog Resource
Summary:

Medical device startups should take notice of the legal case that sent a medical device maker's corporate officers to prison because of clinical trial missteps. Read more about the case.

Read More
Communicating with the FDA? Be proactive, startup veteran says
Baum Stephanie
12/27/2011
Blog Resource
Summary:

When communicating with the FDA during the approval process, it's best to be proactive, says startup veteran Jane Hollingsworth. Read more about her advice for those launching new healthcare businesses.

Read More